Modafinil may alleviate poststroke fatigue: A randomized, placebo-controlled, double-blinded trial

Stroke

Volumn 46, Issue 12, 2015, Pages 3470-3477

  Poulsen, Mai Bang ^a   Damgaard, Bodil ^a,b   Zerahn, Bo ^a   Overgaard, Karsten ^a   Rasmussen, Rune Skovgaard ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

Author keywords

clinical trial; fatigue; randomized controlled trial; rehabilitation; stroke

Indexed keywords

MODAFINIL; PLACEBO; BENZHYDRYL DERIVATIVE; WAKEFULNESS PROMOTING AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DRY EYE; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; OUTCOME ASSESSMENT; POSTSTROKE FATIGUE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RASH; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SLEEP DISORDER; XEROSTOMIA; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; STROKE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME; WAKEFULNESS-PROMOTING AGENTS;

EID: 84948067409     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.010860     Document Type: Article

References (42)

1. Mücke M, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L, Mochamat Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015 5 CD006788. doi: 10.1002/14651858.CD006788.pub3.
2. Duncan F, Wu S, Mead GE., Frequency and natural history of fatigue after stroke: a systematic review of longitudinal studies. J Psychosom Res 2012 73 18 27. doi: 10.1016/j.jpsychores.2012.04.001.
3. van de Port IG, Kwakkel G, Schepers VP, Heinemans CT, Lindeman E., Is fatigue an independent factor associated with activities of daily living, instrumental activities of daily living and health-related quality of life in chronic stroke? Cerebrovasc Dis 2007 23 40 45
4. Lerdal A, Gay CL., Fatigue in the acute phase after first stroke predicts poorer physical health 18 months later. Neurology 2013 81 1581 1587. doi: 10.1212/WNL.0b013e3182a9f471.
5. Andersen G, Christensen D, Kirkevold M, Johnsen SP., Post-stroke fatigue and return to work: a 2-year follow-up. Acta Neurol Scand 2012 125 248 253. doi: 10.1111/j.1600-0404.2011.01557.x.
6. Glader EL, Stegmayr B, Asplund K., Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden. Stroke 2002 33 1327 1333
7. Pollock A, St George B, Fenton M, Firkins L., Top ten research priorities relating to life after stroke. Lancet Neurol 2012 11 209. doi: 10.1016/S1474-4422(12)70029-7.
8. Ingles JL, Eskes GA, Phillips SJ., Fatigue after stroke. Arch Phys Med Rehabil 1999 80 173 178
9. Kutlubaev MA, Mead GE, Lerdal A., Fatigue after stroke-perspectives and future directions. Int J Stroke 2015 10 280 281. doi: 10.1111/ijs.12428.
10. Wu S, Mead G, Macleod M, Chalder T., Model of understanding fatigue after stroke. Stroke 2015 46 893 898. doi: 10.1161/STROKEAHA.114.006647.
11. Choi-Kwon S, Han SW, Kwon SU, Kim JS., Poststroke fatigue: characteristics and related factors. Cerebrovasc Dis 2005 19 84 90. doi: 10.1159/000082784.
12. Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS., Fluoxetine is not effective in the treatment of post-stroke fatigue: a double-blind, placebo-controlled study. Cerebrovasc Dis 2007 23 103 108. doi: 10.1159/000097045.
13. Karaiskos D, Tzavellas E, Spengos K, Vassilopoulou S, Paparrigopoulos T., Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue. J Neuropsychiatry Clin Neurosci 2012 24 349 353. doi: 10.1176/appi.neuropsych.11110325.
14. Kumar R., Approved and investigational uses of modafinil: an evidence-based review. Drugs 2008 68 1803 1839
15. Ballon JS, Feifel D., A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 2006 67 554 566
16. Minzenberg MJ, Carter CS., Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 2008 33 1477 1502. doi: 10.1038/sj.npp.1301534.
17. Simon P, Hémet C, Ramassamy C, Costentin J., Non-Amphetaminic mechanism of stimulant locomotor effect of modafinil in mice. Eur Neuropsychopharmacol 1995 5 509 514
18. Rush CR, Kelly TH, Hays LR, Baker RW, Wooten AF., Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol 2002 13 105 115
19. Brioschi A, Gramigna S, Werth E, Staub F, Ruffieux C, Bassetti C, Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol 2009 62 243 249. doi: 10.1159/000232927.
20. Smets EM, Garssen B, Bonke B, De Haes JC., The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995 39 315 325
21. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD., The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989 46 1121 1123
22. Lerdal A, Kottorp A., Psychometric properties of the Fatigue Severity Scale-Rasch analyses of individual responses in a Norwegian stroke cohort. Int J Nurs Stud 2011 48 1258 1265. doi: 10.1016/j.ijnurstu.2011.02.019.
23. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J., Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988 19 604 607
24. Shah S, Vanclay F, Cooper B., Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989 42 703 709
25. Maribo T, Lauritsen JM, Waehrens E, Poulsen I, Hesselbo B., Barthel Index for evaluation of function: a Danish consensus on its use. Ugeskr Laeger 2006 168 2790 2792
26. Lindenstrom E, Boysen G, Christiansen LW, Hansen BR, Nielsen PW., Reliability of Scandinavian neurological stroke scale. Cerebrovasc. Dis 1991 1 103 107
27. Jones CJ, Rikli RE, Beam WC., A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 1999 70 113 119. doi: 10.1080/02701367.1999.10608028.
28. Podsiadlo D, Richardson S., The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991 39 142 148
29. Meyer DE, Osman AM, Irwin DE, Yantis S., Modern mental chronometry. Biol Psychol 1988 26 3 67
30. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W., The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001 66 159 164
31. Muus I, Williams LS, Ringsberg KC., Validation of the Stroke Specific Quality of Life Scale (SS-QOL): test of reliability and validity of the Danish version (SS-QOL-DK). Clin Rehabil 2007 21 620 627. doi: 10.1177/0269215507075504.
32. Williams LS, Weinberger M, Harris LE, Clark DO, Biller J., Development of a stroke-specific quality of life scale. Stroke 1999 30 1362 1369
33. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005 53 695 699. doi: 10.1111/j.1532-5415.2005.53221.x.
34. Cumming TB, Churilov L, Linden T, Bernhardt J., Montreal cognitive assessment and mini-mental state examination are both valid cognitive tools in stroke. Acta Neurol Scand 2013 128 122 129. doi: 10.1111/ane.12084.
35. Urban KR, Gao WJ., Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. Front Syst Neurosci 2014 8 38. doi: 10.3389/fnsys.2014.00038.
36. Johansson B, Wentzel AP, Andréll P, Mannheimer C, Rönnbäck L., Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury. Brain Inj 2015 29 758 765. doi: 10.3109/02699052.2015.1004747.
37. Jha A, Weintraub A, Allshouse A, Morey C, Cusick C, Kittelson J, A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil 2008 23 52 63. doi: 10.1097/01.HTR.0000308721.77911.ea.
38. Kaiser PR, Valko PO, Werth E, Thomann J, Meier J, Stocker R, Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. Neurology 2010 75 1780 1785. doi: 10.1212/WNL.0b013e3181fd62a2.
39. Awudu GA, Besag FM., Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder: an update. Drug Saf 2014 37 661 676. doi: 10.1007/s40264-014-0201-8.
40. Johansson B, Carlsson A, Carlsson ML, Karlsson M, Nilsson MK, Nordquist-Brandt E, Placebo-controlled cross-over study of the monoaminergic stabiliser (-)-OSU6162 in mental fatigue following stroke or traumatic brain injury. Acta Neuropsychiatr 2012 24 266 274. doi: 10.1111/j.1601-5215.2012.00678.x.
41. Wesensten NJ, Killgore WD, Balkin TJ., Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 2005 14 255 266. doi: 10.1111/j.1365-2869.2005.00468.x.
42. Tseng BY, Billinger SA, Gajewski BJ, Kluding PM., Exertion fatigue and chronic fatigue are two distinct constructs in people post-stroke. Stroke 2010 41 2908 2912. doi: 10.1161/STROKEAHA.110.596064.